Rose Merc grants 20,000 stock options at Rs 70 each
Rose Merc Limited granted 20,000 stock options to three employees under ESOP Plan II 2023 at an exercise price of Rs 70 per share. The options vest after one year and can be exercised over a four-year period. Shares issued upon exercise will not be subject to lock-in.

*this image is generated using AI for illustrative purposes only.
Rose Merc Limited has granted 20,000 stock options to three eligible employees under its RML Employee Stock Option Plan II 2023. The Compensation Committee approved the grant at a meeting held on June 23, 2026. Each option entitles the holder to apply for one equity share of the company with a face value of Rs 10.
The exercise price for the options is fixed at Rs 70 per option. The scheme is compliant with the SEBI (SBEBSE) Regulations, 2021. The options will vest at the completion of one year from the date of the grant.
Following vesting, the options can be exercised either wholly or partly within an overall exercise period of four years from the date of respective vesting. The Compensation Committee retains the authority to modify this exercise period.
The plan is administered by the company's Compensation Committee and includes provisions for handling options in cases of death, permanent incapacity, resignation, termination, or retirement. Adjustments to the number of options will be made in the event of corporate actions such as rights issues, bonus issues, share splits, consolidations, mergers, or reorganizations.
Equity shares allotted upon the exercise of these stock options will not be subject to any lock-in period. These shares will rank pari-passu with existing equity shares from the date of allotment.
| Particulars | Details |
|---|---|
| Options Granted | 20,000 |
| Eligible Employees | 3 |
| Exercise Price | Rs 70 per option |
| Face Value of Share | Rs 10 |
| Vesting Period | 1 year |
| Exercise Period | 4 years from vesting |
Historical Stock Returns for Rose Merc
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.82% | +3.66% | +2.31% | -11.64% | +51.83% | +1,687.63% |
What impact will the dilution from these 20,000 options have on existing shareholders' equity?
How does the exercise price of Rs 70 compare to the company's current market valuation?
What performance metrics or criteria were used by the Compensation Committee to select these three specific employees?

































